Patents - Global Data - Dimensions
SOLID ORAL NICOTINE FORMULATION
Applicants:
- Fertin Pharma (Denmark) [NORA names: Fertin Pharma; Private Research; Denmark; Europe, EU; Nordic; OECD]
- Fertin Pharma AS [NORA names: Fertin Pharma; Private Research]
- Individual [NORA names: Miscellaneous; Miscellaneous]
Abstract
A solid oral nicotine formulation is disclosed, the formulation comprises a nicotine-ion exchange resin combination, and a salt comprising inorganic divalent cations, wherein the salt has a water-solubility of at least 5 grams per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH 7.0.
Patent Family Records (5)
Solid oral nicotine formulation
Fertin Pharma (Denmark), Fertin Pharma AS NIELSEN KENT ALBIN, POULSEN JESSIE
2024, US-11911375-B2
SOLID ORAL NICOTINE FORMULATION
Fertin Pharma (Denmark), Fertin Pharma AS NIELSEN KENT ALBIN, POULSEN JESSIE
2023, EP-4243823-A1
SOLID ORAL NICOTINE FORMULATION
FERTIN PHARMA AS, Fertin Pharma (Denmark) NIELSEN KENT ALBIN, POULSEN JESSIE
2022, WO-2022100806-A1
SOLID ORAL NICOTINE FORMULATION
Fertin Pharma (Denmark), Fertin Pharma AS NIELSEN KENT ALBIN, POULSEN JESSIE
2022, US-20220152013-A1
SOLID ORAL NICOTINE FORMULATION
Individual NIELSEN KENT ALBIN, POULSEN JESSIE
2022, CA-3173082-A1
